Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Blocking interferon-gamma might help treat various autoimmune diseases.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.

Hair follicle cells resist turning into skin cells.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Keratin is crucial for keeping skin cells healthy and its changes can lead to diseases and affect cell behavior.

The document concludes that patients with skin of color need specialized dermatological care and education to manage unique skin conditions effectively.

Blocking DGAT1 reduces oil gland size in mice and dogs, but only mice experience hair loss.

CD201+ fascia progenitors are essential for wound healing and could be targeted for treating skin conditions.

Beard hair loss can signal early diabetes and thyroid issues, treatable with specific cream.

The mTOR pathway proteins are altered in the hair follicles of patients with Lichen Planopilaris and Frontal Fibrosing Alopecia.

Skin symptoms without a medical cause often reflect psychological stress and are influenced by culture, requiring a team approach for treatment.

Treating both the mind and skin together, especially by managing stress, can greatly improve outcomes for skin disorders linked to psychological issues.

Dermoscopy greatly improves melanoma diagnosis and reduces unneeded surgeries.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

The document discusses a condition causing hair loss after surgery and a type of rosacea affecting the nose, with treatments including surgery and laser therapy.

All medications can cause skin rashes, often without a clear cause, and better tests are needed to identify these drug-related skin issues.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

The research reveals how early embryonic mouse skin develops from simple to complex structures, identifying various cell types and their roles in this process.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Terbinafine can cause hair loss.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Lipid nanoparticles improve drug delivery through the skin, offering stability, controlled release, and better compatibility with skin.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

The study suggests that people with rosacea are more likely to have chronic rhinosinusitis.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

The document explains the genetic causes and characteristics of inherited hair disorders.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.